Kelly Financial Services’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-234
| Closed | -$459 | – | 587 |
|
|
2024
Q2 | $459 | Hold |
234
| – | – | ﹤0.01% | 710 |
|
|
2024
Q1 | $555 | Hold |
234
| – | – | ﹤0.01% | 703 |
|
|
2023
Q4 | $505 | Hold |
234
| – | – | ﹤0.01% | 704 |
|
|
2023
Q3 | $491 | Hold |
234
| – | – | ﹤0.01% | 683 |
|
|
2023
Q2 | $669 | Hold |
234
| – | – | ﹤0.01% | 635 |
|
|
2023
Q1 | $681 | Hold |
234
| – | – | ﹤0.01% | 611 |
|
|
2022
Q4 | $686 | Hold |
234
| – | – | ﹤0.01% | 584 |
|
|
2022
Q3 | $562 | Sell |
234
-28
| -11% | -$67 | ﹤0.01% | 602 |
|
|
2022
Q2 | $587 | Hold |
262
| – | – | ﹤0.01% | 598 |
|
|
2022
Q1 | $603 | Hold |
262
| – | – | ﹤0.01% | 595 |
|
|
2021
Q4 | $655 | Hold |
262
| – | – | ﹤0.01% | 613 |
|
|
2021
Q3 | $831 | Buy |
+262
| New | +$831 | ﹤0.01% | 575 |
|